com/reports/c12677) has
announced the addition of New Zealand Medical Devices Market Outlook -
Market Intelligence Report to their offering. Executive Summary

2 . Sources

For more information visit
http://www., Reliv International,
Inc.
Robert L., based in suburban St. Eastern Time on August 3, 2005.reliv.com .5% 18.8%
Mexico 5,880 420 7,740 760 -24.8%
Malaysia/Singapore 3,780 680 4,080 520 -7.8%

Consolidated
total 70,230 15,180 67,900 12,170 3.6% 5,642 27.6% 378 1.8% -371 -55.6% 776 1.

sports spain

researchandmarkets . Company Delivers 65 Percent Increase in Net Income with 19 Percent Growth in
Net Sales

CHESTERFIELD, Mo."
Introduced in February 2005, CardioSentials (TM) generated sales of
$1.m.
For more information about Reliv, please visit our website at
http://www. and Subsidiaries

Active Distributors and Master Affiliates by Region

as of 6/30/2005 as of 6/30/2004 Change in %

Master Master Master
Distrib- Affil- Distrib- Affil- Distrib- Affil-
utors iates utors iates utors iates
United States 50,240 13,090 45,040 9,870 11.0%
Philippines 5,640 500 6,510 580 -13.0% 4,655 19.5% 41,017 86.0% 10,156 21.

sports around

Importantly, the market can be seen
in its global context with international market comparisons . This new dietary supplement is attracting attention in the
marketplace, in part because it was shown through an independent clinical
study to be safe and effective in reducing cholesterol levels , a significant
risk factor for heart disease. Montgomery noted that the company entered its 11th country worldwide,
when Reliv opened for business in Germany on July 18. Louis, manufactures and
distributes several lines of food products, including nutritional and fiber
supplements, diet management products, functional foods, sports drink mixes
and a line of premium skin care products .
Reliv will host a conference call to discuss the second quarter 2005
earnings with investors at 1:00 p. The
dial-in number for investors is 866-271-5140.17

Weighted average
shares of common
stock and common
stock equivalents
outstanding
Basic 16,096,000 15,393,000 16,216,000 15,285,000

Diluted 16 ,622,000 17,389,000 16,825,000 16,976,000

Reliv International, Inc.0% 0 0.6%
Canada 907 1.9%
Mexico 835 1.5%
United Kingdom/
Ireland 402 0.1%
Philippines 1,280 2.

official water

researchandmarkets . Reliv
reported mixed results from its international markets, with strong growth in
Canada (up 20 percent) and the United Kingdom/Ireland (up 62 percent) offset
by sales declines in other international operations. To register, please call in 15 minutes prior to start of call. Editors and investors are cautioned
that forward-looking statements involve risk and uncertainties that may affect
the Company 's business prospect and performance. This includes economic,
competitive, governmental, technological and other factors discussed in the
Company's filings with the SEC on forms 10-K and 10-Q. and Subsidiaries

Condensed Consolidated Balance Sheets
June 30 December 31
2005 2004
(Unaudited)

Assets
Current Assets:
Cash and cash equivalents $5,836,812 $10,151,503
Accounts and notes receivable, less
allowances of $23,700 in 2005 and
$11,500 in 2004 568,017 872,592
Accounts due from employees and distributors 81,850 70,620
Inventories 6,561,068 5,896 ,782
Other current assets 2,058,746 2,627,118

Total current assets 15,106,493 19,618,615
Other assets 1,866,420 1,409,903
Net property, plant and equipment 10 ,502,930 9,968,149

Total Assets $27,475,843 $30,996 ,667

Liabilities and Stockholders' Equity

Total current liabilities $13,121,395 $8,151,968
Total non-current liabilities 3,446,366 4,653,946
Stockholders' equity 10,908,082 18,190,753

Total Liabilities and Stockholders' Equity $27,475,843 $30,996,667

Consolidated Statements of Income

Three months ended June 30 Six months ended June 30
2005 2004 2005 2004
(Unaudited ) (Unaudited) (Unaudited) (Unaudited)
Sales at Retail $41,055,868 $34,280,799 $83,011 ,088 $68,139,940
Less: Distributor
allowances on
product purchases 12,509 ,782 10,389,594 25,485,906 20,770,903

Net Sales 28,546,086 23,891,205 57,525,182 47,369,037

Costs and expenses:
Cost of products
sold 4,711,472 4,000,626 9,654,776 7,854,905
Distributor
royalties and
commissions 11,379,011 9,562,686 23,090,727 18,883,076
Selling,
general and
administrative 9,190,021 8,314,261 18,153,307 15,835,211

Total Costs and
Expenses 25,280,504 21,877,573 50,898,810 42,573,192

Income from
operations 3,265,582 2,013,632 6,626,372 4,795,845
Other income
(expense):
Interest
expense, net (37,664) (18 ,788) (53,131) (63,549)
Other income, net 45,856 8,023 48,922 22,218

Income before
income taxes 3,273,774 2,002,867 6,622,163 4,754,514
Provision for
income taxes 1,295,000 802,000 2,580,000 1 ,912,000

Net Income 1,978,774 1,200,867 4,042,163 2,842,514

Preferred
dividends
accrued and paid - - - 12 ,292

Net income
available to
common
shareholders $1,978,774 $1,200,867 $4,042,163 $2,830,222

Earnings per
common share
Basic $0.5% 32.4% 30.6%
Australia/
New Zealand 505 1 .7% 674 2.0% 47,369 100.

college rowing

We estimate the current size of the New Zealand market for medical
equipment +supplies to be US$237 million. As a
result, around 90% of the market is supplied by imports, primarilyfrom
the USA and Australia. Reliv International's common
stock trades on The Nasdaq Stock Market(R) under the symbol RELV.com/us/investor .08 $0.6%
Mexico 293 1.9%
Germany 0 0.5%

Net sales by Region Six months ended June 30
(in thousands)
2005 2004 Change from
$ % of $ % of prior Change
sales sales year in %
United States 52,057 90.

ireland zealand

5 million -- compared to $47.3 million
during the first six months of 2004. net
product sales. A
replay of this call will be available for one week by telephone from 3:00 p .4% 20,446 85.6%
Canada 456 1.6% 78 20.4% -77 -6 .9% -90 -6.0% -461 -32.0% 0 0.4%

ireland canada

Business Editors/Health /Medical Writers

DUBLIN, Ireland----Research and
Markets (http://www.
Medistat Outlook Reports are ideal for executives wanting to
understand the key drivers in medical markets worldwide.S.
Mr. We are excited about the opportunity
to build a growing presence for Reliv in this largely untapped market.
Eastern by calling 888-286-8010 and using pass code 55342707. A live web cast
of this call will be available through the Investor Relations section of
Reliv's Web site, http://www .9%
United Kingdom/
Ireland 235 0.0% 23,891 100.

sports canada

Research and Markets: New Zealand Medical Devices Market Outlook - Market Intelligence Report

Key National Data Projections

4.7% 4.0% -44.7%
United Kingdom/
Ireland 530 60 410 50 29.6% 11,040 26.

college water

Each report
provides a comprehensive analysis of the market and, importantly,
provides 5-year forecasts by technology category, national data
projections , outlook and key developments such as regulation, health
facilities and government policy. International Market Comparisons

5. U." Along
with Germany, Reliv now sells its products in 10 other countries: United
States, Australia, Canada, Ireland, Malaysia, Mexico, the Philippines,
Singapore, New Zealand , and the United Kingdom. Please access the web
site at least 15 minutes before the scheduled conference call to register.

NOTE: Any statement released by Reliv International, Inc.

-- FINANCIAL HIGHLIGHTS FOLLOW -

Reliv International, Inc.4% -60 -10.9% 1,158 2.0% 0 0.

around zealand

(Nasdaq: RELV), an international manufacturer and network marketer of
nutritional supplements and other food technology products, today announced
its results of operations for the three months ended a 43 percent increase versus the prior-year period.1 million in the second quarter -- or approximately 5 percent of U. Participant pass code is
30789299.m. An online archive of the
broadcast will be available on Reliv's Web site in the Investor Relations
section twenty-four hours after the call concludes.07 $0.24 $0.4% -13.1%
Philippines 479 1.9%
Malaysia/Singapore 490 1.0% 0 0.6%
Malaysia/Singapore 963 1.4%
Germany 0 0.

teams australia

New Zealand is around the
world's 40th largest market, with an overall size similar to that in
Romania or Hong Kong.12 $0.12 $0 .3% 20.8% -195 -28.6% 131 16.7% 289 0.6% 113 39.

canada rowing

com/reports /c12677

Reliv International Reports Second Quarter 2005 Results of Operations

S.
We intend to build on those results in the second half of the year, by
leveraging the strength of an exciting new market, and the growing popularity
of products like CardioSentials(TM).reliv. that is forward
looking is made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995.0% 664 2.7% 1,019 4.9%
Australia/
New Zealand 1,081 1.7% 1,424 3.

college australia

First-half
net sales grew 21 percent, reaching $57. net sales climbed 28 percent
in the second quarter of 2005 compared to the same period last year. "It is an extremely
attractive market for us," Mr. Montgomery said, "not only because it is one of
the top five countries in the world for direct selling, but it also represents
our first foray into continental Europe.

6%
Australia/
New Zealand 2,790 240 2,770 230 0.3%
Canada 1,370 190 1,350 160 1.0%

Consolidated
Total 28,546 100.2% 1,370 2.

official rowing

This is equal to US$59 per
capita, a similar level of spending tothat found in Spain or the UAE,
but around US$8 lower than in Australia.25 $0.7%

Net sales by Region Three months ended June 30
(in thousands)
2005 2004 Change from
$ % of $ % of prior Change
sales sales year in %
United States 26,088 91.3% -529 -51.5% 1,335 2.

Official sites for College and University rowing teams around the world.

rowing australia

New Zealand has very little domestic medical
equipment manufacturing; what is producedtends to be exported.

1. Medical Device Market

3.
Sales growth in the United States, Reliv's largest market, continues to
set the pace for Reliv's overall results. Montgomery, President and Chief Executive Officer of Reliv,
said, "We are particularly pleased to see exceptional earnings growth in the
second quarter, rewarding our shareholders for the outstanding sales
performance we continue to achieve in the United States and other key markets.
Reliv International, Inc. Its proprietary product lines
include an extensive line of soy-based products.19

Diluted $0.4% 24.8% 565 2.8% 145 0.6% 90 62.8% -500 -37.0%

Consolidated
Total 57,525 100.